Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

This study is collecting detailed genetic and molecular information from patients with advanced or metastatic pancreatic cancer to better understand what drives tumor growth and to identify potential new treatment targets. **You may be eligible if...** - You are over 18 with confirmed advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) - You have received no more than one prior chemotherapy treatment for metastatic disease - Tumor tissue (from surgery or biopsy) is available for testing - You have a life expectancy of more than 3 months - You are in good overall health (performance status 0 or 1) **You may NOT be eligible if...** - A curative treatment option is still available to you - You cannot safely provide blood samples - You have another active cancer that is growing or being treated Talk to your doctor to see if this trial is right for you.